Here we report on a bioresorbable fluorescence sensor for in vivo pH monitoring. The sensor leverages a nanometer-thick multilayer stack of polyelectrolytes labelled with a pH-insensitive fluorophore ...

Dao, MC, Everard, A, Aron-Wisnewsky, J, Sokolovska, N, Prifti, E, Verger, EO, et al. Akkermansia Muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with ...

Since this study primarily focuses on analyzing the impact of gut microbiota changes on colitis, we observed that the PD-L1 knockout mice showed marked depletion of mucin-protective species ...

The article presents for the first time a pill-based ingestible electronics with CMOS integrated multiplexed fluorescence bio-molecular sensor arrays, bi-directional wireless communication and ...

VIVES Partners created The Akkermansia Company in 2016, from its outset bringing together a solid consortium of shareholders, including an €18M funding in 2018 with two key lead investors ...

The Akkermansia Company (TAC) was recently acquired by Danone. TAC’s founding scientists first discovered the biotic strain Akkermansia muciniphila MucT in 2004 and have since developed it using ...

Danone has acquired Belgian biotics firm The Akkermansia Company (TAC), strengthening its position in gut health and expanding its science-driven portfolio in line with its Renew strategy.

Danone Invests Further in Gut Health and Next-Generation Biotic ScienceWILMINGTON, Del., June 25, 2025 (GLOBE NEWSWIRE) -- The Akkermansia Company (TAC) today announces that it has been acquired ...

The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form.

Intrinsic tryptophan fluorescence spectroscopy is an important tool for examining the effects of molecular crowding and confinement on the structure, dynamics, and function of proteins. Synthetic ...

After becoming available in its Belgian home market in 2021, the company is now expanding sales of Akkermansia muciniphila MucT ® into key markets in Europe, North America and Asia.

TAC develops health products based on the unique properties of the Akkermansia muciniphila commensal bacterial species. The company has broad patents protecting the use of the Akkermansia species, ...